CN Stock MarketDetailed Quotes
301333 R&G PharmaStudies
- 66.28
- -0.72-1.07%
Market Closed Nov 7 15:00 CST
6.40BMarket Cap52.85P/E (TTM)
68.77High65.03Low14.32KlotVolume66.32Open67.00Pre Close95.18MTurnover2.50%Turnover Ratio39.38P/E (Static)96.58MShares78.2752wk High3.56P/B3.80BFloat Cap33.0552wk Low80.40Limit Up57.31MShs Float83.33Historical High53.60Limit Down5.58%Amplitude33.05Historical Low0.20Dividend TTM66.47Avg Price8.17KlotAsk0.30%Div YieldTTM100Lot Size5.26KlotBid
R&G PharmaStudies Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 2.86%559.45M | 10.75%359.22M | 11.89%171.28M | 14.57%758.9M | 14.13%543.89M | 6.22%324.36M | 12.34%153.08M | 6.61%662.41M | 15.14%476.54M | 7.79%305.37M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other operating activities | -41.66%11.51M | -6.15%9.6M | -47.46%3.21M | 140.47%24.52M | 221.24%19.74M | 295.23%10.23M | 947.42%6.11M | 29.49%10.2M | -7.93%6.14M | -58.80%2.59M |
| Cash inflows from operating activities | 1.30%570.97M | 10.23%368.82M | 9.61%174.49M | 16.48%783.42M | 16.77%563.62M | 8.65%334.58M | 16.33%159.19M | 6.90%672.6M | 14.77%482.68M | 6.34%307.96M |
| Goods services cash paid | 12.48%92.2M | -2.83%55.1M | 8.35%26.81M | 13.39%114.9M | 25.31%81.97M | 35.15%56.71M | 4.92%24.75M | 4.34%101.33M | -7.40%65.41M | -18.81%41.96M |
| Staff behalf paid | 6.24%309.98M | 4.81%207.5M | 3.25%103.29M | 5.54%392.39M | -3.16%291.78M | 4.40%197.98M | 8.75%100.04M | 8.16%371.79M | 12.06%301.29M | 13.50%189.64M |
| All taxes paid | -2.27%42.19M | 16.40%30.73M | 22.83%13.37M | 36.32%56.52M | 23.49%43.17M | 23.15%26.4M | 3.79%10.89M | -8.19%41.46M | 2.85%34.96M | -7.11%21.43M |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other operating activities | 20.85%21.19M | 30.40%14.43M | 34.84%7.72M | -1.83%27.04M | -5.82%17.54M | 13.50%11.07M | -13.09%5.72M | -3.66%27.55M | -21.38%18.62M | -33.21%9.75M |
| Cash outflows from operating activities | 7.16%465.56M | 5.34%307.76M | 6.93%151.19M | 8.99%590.85M | 3.37%434.46M | 11.18%292.16M | 6.59%141.4M | 5.34%542.14M | 5.81%420.28M | 2.48%262.78M |
| Net cash flows from operating activities | -18.40%105.41M | 43.91%61.06M | 30.95%23.3M | 47.60%192.56M | 106.98%129.17M | -6.08%42.43M | 324.03%17.79M | 13.87%130.47M | 167.01%62.4M | 36.26%45.18M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -34.78%2.26B | -45.59%1.27B | -32.46%645M | 182.41%4.4B | 793.04%3.47B | 736.33%2.33B | 421.86%955M | 184.83%1.56B | 50.39%388M | 208.89%278M |
| Cash received from returns on investments | -9.70%17.38M | -29.19%9.95M | -1.59%5.67M | 174.17%25.05M | 750.76%19.25M | 813.13%14.06M | 559.33%5.76M | 251.71%9.14M | 71.85%2.26M | 261.00%1.54M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -77.33%5.48K | -82.63%4.2K | ---- | -84.00%24.18K | 1,411.52%24.18K | 1,411.52%24.18K | ---- | 59.37%151.15K | -98.22%1.6K | -95.98%1.6K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash inflows from investing activities | -34.64%2.28B | -45.49%1.27B | -32.28%650.67M | 182.34%4.43B | 792.80%3.48B | 736.76%2.34B | 422.51%960.76M | 185.12%1.57B | 50.45%390.26M | 209.00%279.54M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -18.36%12.48M | -19.90%8.89M | 30.63%3.97M | -4.54%19.88M | 13.28%15.29M | 3.89%11.1M | -44.26%3.04M | -45.60%20.83M | -30.12%13.5M | -30.78%10.68M |
| Cash paid to acquire investments | -36.39%2.62B | -29.78%1.77B | -30.21%820M | 227.98%5.11B | 556.85%4.13B | 808.27%2.53B | 499.49%1.18B | 184.83%1.56B | 131.73%628M | 84.11%278M |
| Net cash paid to acquire subsidiaries and other business units | --21.31M | --21.31M | --21.31M | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash outflows from investing activities | -35.81%2.66B | -28.90%1.8B | -28.25%845.27M | 224.92%5.13B | 545.41%4.14B | 778.50%2.54B | 484.79%1.18B | 169.75%1.58B | 120.97%641.5M | 73.45%288.68M |
| Net cash flows from investing activities | 42.03%-380.3M | -168.12%-528.24M | 10.43%-194.61M | -6,008.45%-704.8M | -161.12%-656.02M | -2,054.87%-197.02M | -1,136.47%-217.28M | 67.58%-11.54M | -712.93%-251.23M | 87.96%-9.14M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.11B | --1.11B | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from borrowing | --54.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other financing activities | --12.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash inflows from financing activities | --67.71M | ---- | ---- | ---- | ---- | ---- | ---- | --1.11B | --1.11B | --0 |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Dividend interest payment | 219.42%18.58M | ---- | ---- | --5.82M | --5.82M | --5.74M | ---- | ---- | ---- | --0 |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash payments relating to other financing activities | 847.12%87.14M | 111.23%13.32M | 220.84%9.25M | -83.77%12.74M | -86.31%9.2M | -87.59%6.31M | -94.01%2.88M | 689.50%78.5M | 855.10%67.22M | 1,034.72%50.81M |
| Cash outflows from financing activities | 604.01%105.71M | 10.59%13.32M | 220.84%9.25M | -76.36%18.56M | -77.66%15.02M | -76.30%12.04M | -94.01%2.88M | 689.50%78.5M | 855.10%67.22M | 1,034.72%50.81M |
| Net cash flows from financing activities | -153.07%-38M | -10.59%-13.32M | -220.84%-9.25M | -101.79%-18.56M | -101.43%-15.02M | 76.30%-12.04M | 94.01%-2.88M | 10,514.60%1.04B | 14,973.22%1.05B | -1,034.72%-50.81M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -159.29%-1.38M | -78.24%616.44K | 113.78%146.34K | -79.72%1.1M | -66.10%2.33M | -7.88%2.83M | -308.14%-1.06M | 528.96%5.44M | 2,240.78%6.87M | 674.10%3.07M |
| Net increase in cash and cash equivalents | 41.75%-314.28M | -192.97%-479.88M | 11.31%-180.42M | -145.67%-529.69M | -162.39%-539.54M | -1,300.09%-163.8M | -229.38%-203.43M | 1,611.41%1.16B | 5,907.63%864.83M | 75.54%-11.7M |
| Add:Begin period cash and cash equivalents | -34.82%991.48M | -34.82%991.48M | -34.82%991.48M | 321.03%1.52B | 321.03%1.52B | 321.03%1.52B | 321.03%1.52B | 23.09%361.3M | 23.09%361.3M | 23.09%361.3M |
| End period cash equivalent | -31.01%677.2M | -62.31%511.6M | -38.45%811.06M | -34.82%991.48M | -19.94%981.64M | 288.27%1.36B | 339.93%1.32B | 321.03%1.52B | 340.05%1.23B | 42.29%349.6M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data